New inhibitor drug shows promise in preventing diabetic eye and kidney disease

New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease.

Exclusive: Employer healthcare company Personify Health says it has $500M+ in revenue, is ‘highly’ profitable

Personify Health, which sells healthcare spending management services to employers, has reached more than half a billion dollars in revenue following the 2023 merger that

February 7, 2025

Sanofi, Regeneron prep another FDA submission for Dupixent, this time for a rare skin condition

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 12, 2024

FDA advisers vote overwhelmingly against ALS treatment from BrainStorm

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the

September 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.